Log in to search using one of your social media accounts:

 

BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy
SAN RAMON, Calif. and CAMBRIDGE, England, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced enrollment of the first patie... Devices, Cardiology BioVentrix, Revivent TC, TransCatheter Ventricular Enhancement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news

After 10 months, Alnylam still can't explain patient trial deaths
More than 10 months after disclosing that patients who received one of its experimental drugs in a late-stage trial had died at a far higher rate than those on placebo, Cambridge-based Alnylam Pharmaceuticals still cannot conclusively explain what went wrong. Alnylam (Nasdaq: ALNY) on Wednesday released the results of its investigation into the deaths of older patients with heart problems who took revusiran, a potential treatment for a deadly inherited disease called hATTR cardiomyopathy. In October,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 10, 2017 Category: American Health Authors: Max Stendahl Source Type: news

After 10 months, Alnylam still can't explain patient trial deaths
More than 10 months after disclosing that patients who received one of its experimental drugs in a late-stage trial had died at a far higher rate than those on placebo, Cambridge-based Alnylam Pharmaceuticals still cannot conclusively explain what went wrong. Alnylam (Nasdaq: ALNY) on Wednesday released the results of its investigation into the deaths of older patients with heart problems who took revusiran, a potential treatment for a deadly inherited disease called hATTR cardiomyopathy. In October,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 10, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

'Exercise pill' could potentially help people with heart failure
Conclusion The protein hCT1 caused heart muscles to grow in a more healthy way in rodents with heart failure. When treatment stopped, the heart went back to its original condition – something that does not happen when the heart grows in a dysfunctional way. There is currently no cure for heart failure and treatment is only available for keeping symptoms under control. Therefore, this very promising early-stage research with potential for developing a drug for people with heart failure, has huge implications. However, it is important to remember that as this is experimental laboratory research, there are man...
Source: NHS News Feed - August 9, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news

MyoKardia ’s Phase II trial for oHCM drug meets endpoints
MyoKardia has reported positive top-line results from the first cohort of its Phase II PIONEER-HCM clinical trial of mavacamten in patients with symptomatic, obstructive hypertrophic cardiomyopathy (oHCM). (Source: Drug Development Technology)
Source: Drug Development Technology - August 7, 2017 Category: Pharmaceuticals Source Type: news

UIowa study examines altered gene expression in heart failure
(University of Iowa Health Care) Heart tissue from patients with heart failure exhibits increased levels of Cdk8 protein. Mimicking this increased Cdk8 expression in transgenic mouse hearts alters gene expression in a way that promotes heart failure. When University of Iowa researchers examined the mouse heart cells before a decrease in heart function was detectable, they found over 3,400 genes already expressed with a profile similar to that of human heart muscle cells with dilated cardiomyopathy and heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2017 Category: International Medicine & Public Health Source Type: news

Researchers successfully edit 1st human embryo with CRISPR
Scientists have successfully edited genes in a human embryo, correcting a disease-causing mutation to prevent the defect from being inherited. The groundbreaking process, covered in a paper published yesterday in Nature, was confirmed last week by the Oregon Health and Science University, which collaborated with the Salk Institute and Korea’s Institute for Basic Science on the task. To edit the genetic mutation, in this case for hypertrophic cardiomyopathy, researchers used a technique known as CRISPR-Cas9. The CRISPR-Cas9 technique operates as a sort of ‘molecular scissors’ which can trim away unwanted p...
Source: Mass Device - August 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Biotech Research & Development Source Type: news

Gene editing used to repair diseased genes in embryos
Conclusion Currently, genetically-inherited conditions like hypertrophic cardiomyopathy cannot be cured, only managed to reduce the risk of sudden cardiac death. For couples where one partner carries the mutated gene, the only option to avoid passing it onto their children is pre-implantation genetic diagnosis. This involves using IVF to create embryos, then testing a cell of the embryo to see whether it carries the healthy or mutated version of the gene. Embryos with healthy versions of the gene are then selected for implantation in the womb. Problems arise if too few or none of the embryos have the correct version of the...
Source: NHS News Feed - August 3, 2017 Category: Consumer Health News Tags: Genetics/stem cells Source Type: news

First human gene editing performed on human embryo
Researchers have successfully used the gene-editing technique CRISPR to correct the gene responsible for hypertrophic cardiomyopathy in a human embryo. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 2, 2017 Category: Consumer Health News Source Type: news

THIS inherited heart condition can cause sudden death - new test could identify risk
HYPERTROPHIC cardiomyopathy is a condition which can cause sudden death. The condition claimed the life of Miles Frost, Sir David Frost's son. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2017 Category: Consumer Health News Source Type: news

Analysis: Primary Prevention ICDs Cut Deaths in Cardiomyopathy Analysis: Primary Prevention ICDs Cut Deaths in Cardiomyopathy
Contrary to recent data, a new meta-analysis reports ICD therapy for primary prevention reduced the risk of death in patients with ischemic and nonischemic cardiomyopathy.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Analysis: Primary-Prevention ICDs Cut Deaths in Cardiomyopathy Analysis: Primary-Prevention ICDs Cut Deaths in Cardiomyopathy
Contrary to recent data, a new meta-analysis reports ICD therapy for primary prevention reduced the risk of death in patients with ischemic and nonischemic cardiomyopathy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 5, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

BioVentrix raises $15m
BioVentrix raised $14.5 million in a new round of equity financing according to an SEC filing posted this week. Funds in the round came from 152 unnamed investors, with the 1st sale marked on July 21, 2016, according to the filing. The company is not seeking anymore funds the round. The company raised the money through the sale of equity and convertible notes, according to the filing. A total of $1.2 million were provided as sales commissions, with the placement agent also receiving warrants to purchase common stock equal to 10% of the number of shares offered in the round at an exercise price of $7.50 per share, according...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News BioVentrix Source Type: news

Meta-Analysis: ICDs Improve Survival in Ischemic and Nonischemic Cardiomyopathy (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Implantable cardioverter-defibrillators (ICDs) improve survival over conventional care in patients with either ischemic or nonischemic cardiomyopathy, finds a meta-analysis in the Annals of Internal Medicine. Last year's DANISH trial questioned … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 27, 2017 Category: Primary Care Source Type: news

Do ICDs Have a Role in Nonischemic Cardiomyopathy? Do ICDs Have a Role in Nonischemic Cardiomyopathy?
Drs Naveen Pererira, Paul Friedman, and Abhishek Deshmukh discuss how clinical trials have shaped preferences for pacemakers, defibrillators, and optimal medical therapy in the treatment of nonischemic cardiomyopathy.Mayo Clinic (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2017 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy
Tuesday, June 6, 2017 - Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis, the company ’s investigational treatment for transthyretin cardiomyopathy (TTR-CM). This... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 6, 2017 Category: Drugs & Pharmacology Source Type: news

FDA grants fast-track status to Pfizer ’s tafamidis to treat TTR-CM
The US Food and Drug Administration (FDA) has granted fast-track designation to Pfizer ’s investigational candidate, tafamidis, for the treatment of patients with transthyretin cardiomyopathy (TTR-CM). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 6, 2017 Category: Pharmaceuticals Source Type: news

Pfizer receives FDA Fast Track designation for tafamidis for transthyretin cardiomyopathy
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis, the company's investigational treatment for transthyretin cardiomyopathy (TTR-CM). This rare disease is associated with progressive heart failure and is universally fatal.(1,2,3) Currently in Phase 3 clinical development for TTR-CM, tafamidis is being evaluated for its potential to reduce mortality and cardiovascular-related hospitalizations.(4) (Source: World Pharma News)
Source: World Pharma News - June 6, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Quitting Meth Is Necessary to Improve Related Cardiac Symptoms, Study Suggests (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH Methamphetamine users who develop cardiomyopathy see symptom improvement only when they stop using the drug, according to a JACC: Heart Failure study.Researchers in Germany studied 30 … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 30, 2017 Category: Primary Care Source Type: news

Do men have worse chemotherapy-induced cardiomyopathy than women?
(European Society of Cardiology) Men seem to have worse chemotherapy-induced cardiomyopathy than women despite receiving similar cancer treatments, according to research presented today at EuroCMR 2017. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2017 Category: International Medicine & Public Health Source Type: news

BioVentrix touts 1st clinical use of Revivent for ischemic cardiomyopathy
BioVentrix said yesterday that its Revivent TC transcatheter ventricular enhancement system saw its 1st clinical use in treating ischemic cardiomyopathy at Berlin, Germany’s Deutsches Herzzentrum. The device was used by interventional cardiologist Dr. Cristoph Klein and Dr. Felix Hennig, with assitance from Dr. Sebastian Kelle, according to BioVentrix. The Revivent system is designed to eliminate the need for cardiopulmonary bypass or incisions in the heart by enabling the placement of small titanium anchors along the heart’s outer surface and along one of the inside walls, according to the San Ramon, Cali...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters BioVentrix Source Type: news

Researchers receive NIH grant to study heart problems at the molecular level
(Washington State University) Washington State University researchers have received a $1.57 million National Institutes of Health grant to understand the molecular-scale mechanisms that cause cardiomyopathy, or heart muscle disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 18, 2017 Category: Biology Source Type: news

Celyad receives FDA fast-track status for C-Cure to treat ischemic heart failure
Belgian biopharmaceutical firm Celyad has secured fast-track designation from the US Food and Drug Administration (FDA) for its C-Cure ® therapy for patients with chronic heart failure, secondary to ischemic cardiomyopathy with baseline Left Ventricul … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 11, 2017 Category: Pharmaceuticals Source Type: news

Jimmy Kimmel Made Me Cry
Jimmy Kimmel is one funny guy. Do you remember when he duped the world with a video of a twerking girl who caught on fire? Almost 23 million people (suckers) watched that video. That’s the equivalent of every single person living in Ohio and Pennsylvania! What about his stunt at the Oscars when his mother made and served PB&J sandwiches to the celebrity audience? Classic. Given all of his antics, I never expected that Jimmy would make me cry. I never imagined that I would see Jimmy act like me, scared and completely vulnerable. This wasn’t a sketch. This was real life. On April 28, Jimmy and his wife welcom...
Source: Healthy Living - The Huffington Post - May 3, 2017 Category: Consumer Health News Source Type: news

Dilated cardiomyopathy
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 28, 2017 Category: Consumer Health News Source Type: news

TTN Mutation May Not Rule Out Medical Therapy for Dilated Cardiomyopathy TTN Mutation May Not Rule Out Medical Therapy for Dilated Cardiomyopathy
In patients with dilated cardiomyopathy, loss-of-function mutations in the titin gene (TTN) do not preclude systolic function recovery following standard pharmacological therapy, according to Canadian researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 26, 2017 Category: Radiology Tags: News Source Type: news

GSU researchers get $2.8 million to study diabetic cardiomyopathy
Georgia State University researchers received a $2.8 million grant from the federal government to study diabetic cardiomyopathy, or diabetes-related changes in the structure and function of the heart. The National Heart, Lung and Blood Institute awarded the four-year grant to Dr. Zhonglin Xie, associate professor at GSU's Center for Molecular and Translational Medicine, and Dr. Ming-Hui Zou, director of the center and a Georgia Research Alliance Eminent Scholar. The researchers will use the fun ds… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2017 Category: American Health Authors: Ellie Hensley Source Type: news

Georgia State researchers get $2.8 million grant to study cause of diabetic cardiomyopathy
(Georgia State University) Researchers from Georgia State University's Center for Molecular& Translational Medicine have received a four-year, $2.8 million federal grant to study diabetic cardiomyopathy, diabetes-related changes in the structure and function of the heart muscle. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2017 Category: Biology Source Type: news

Apr 14 Cardiology News Apr 14 Cardiology News
Cardiac arrest care setting, ICDs in patients with nonischemic cardiomyopathy, BP control, readmissions in the elderly with HF, and cardiologists'pay are discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 14, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Meet the girl who has had four hearts – video
Born with a serious heart condition called dilated cardiomyopathy, Chloe Narbonne had five major operations – and four hearts – by the age of 12. She defied the odds to become the youngest person in Europe to receive an artificial heart thanks to groundbreaking surgery involving 30 NHS staff. Now Chloe, her mother and medical personnel tell her amazing story for the first timeContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 10, 2017 Category: Science Authors: Denis CampbellDavid LeveneKen MacfarlaneMichael Tait Tags: Health Doctors NHS Society UK news Medical research Science Source Type: news

What Are the Clinical Symptoms Associated with Friedreich Ataxia?
Discussion Friedreich ataxia (FRDA) was first extensively described in a series of papers from 1863-1877 by Nikolaus Friedreich at the University of Heidelberg, Germany. In 1996 the genetic mutation was described. It is an autosomal recessively inherited, homologous expansion of the GAA repeat in intron 1 of the frataxin gene on chromosome 9q13. It causes a transcription error leading to a decrease in frataxin which is a mitochondrial protein involved in iron metabolism and other cell functions. Frataxin is seen mainly in the central and peripheral nervous systems, heart, pancreas and skeleton. Frataxin is produced but in ...
Source: PediatricEducation.org - April 10, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Viral cardiomyopathy: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Daniel Yip explains cardiomyopathy. To listen, click the link below. Viral cardiomyopathy (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 10, 2017 Category: Databases & Libraries Source Type: news

Stem Cell - Sheet Transplantation Feasible in Cardiomyopathy
Small improvement seen over one year in early study (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 6, 2017 Category: Respiratory Medicine Tags: Cardiology, Pathology, Pulmonology, Journal, Source Type: news

Adding Defibrillator to CRT No Benefit in Dilated Cardiomyopathy
However, benefit is seen for addition of defibrillator therapy in patients with ischemic cardiomyopathy (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 3, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Pulmonology, Journal, Source Type: news

Psoriasis and Cardiomyopathy: A Review of the Literature Psoriasis and Cardiomyopathy: A Review of the Literature
The incidence of dilated cardiomyopathy is 10 times higher in patients with psoriasis than in the general population. What might be the possible etiology of this association?Southern Medical Journal (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 30, 2017 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Spectrum Health Cardiomyopathy Program named National Center of Excellence
(Spectrum Health) The Spectrum Health Hypertrophic Cardiomyopathy Program has been designated a national Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA). Spectrum Health joins 25 other centers with this recognition, and becomes the second center in the state of Michigan. Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder, and affects at least 1 in 500 people in the United States. HCMA Centers of Excellence are recognized for providing comprehensive diagnostic, treatment, education and research programs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2017 Category: Global & Universal Source Type: news

Pathologists and Clinical Laboratories May Soon Have a Test for Identifying Cardiac Patients at Risk from Specific Heart Drugs by Studying the Patients ’ Own Heart Cells
Stanford University School of Medicine researchers grew heart muscle cells and used them, along with CRISPR, to predict whether a patient would benefit or experience bad side effects to specific therapeutic drugs What would it mean to pathology groups if they could grow heart cells that mimicked a cardiac patient’s own cells? What if clinical […] (Source: Dark Daily)
Source: Dark Daily - March 22, 2017 Category: Laboratory Medicine Authors: jude Tags: Digital Pathology Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology cardiomyocytes cardiomyopathy clinical laboratory clustered regularly intersp Source Type: news

Brisk Walking Can Help in Hypertrophic Cardiomyopathy Brisk Walking Can Help in Hypertrophic Cardiomyopathy
The study"provides support for a regimen of unsupervised brisk walking 4 to 7 days per week for a minimum of 30 minutes, as a targeted intervention for patients with hypertrophic cardiomyopathy."Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 18, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Study shows moderate exercise may aid HCM patients
Research suggests a change in current guidelines for people with hypertrophic cardiomyopathy to include moderate exercise. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 17, 2017 Category: Consumer Health News Source Type: news

Moderate exercise may be beneficial for HCM patients
Patients with hypertrophic cardiomyopathy are urged to take it easy. But new research shows they might benefit from moderate aerobic exercise. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 17, 2017 Category: Science Source Type: news

Moderate exercise may be beneficial for HCM patients
(Michigan Medicine - University of Michigan) Patients with hypertrophic cardiomyopathy are urged to take it easy. But new research shows they might benefit from moderate aerobic exercise. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2017 Category: Global & Universal Source Type: news

Medical News Today: Immune cell may turn heart inflammation into heart failure
New research examines the role of a type of white blood cells called eosinophils on heart inflammation, dilated cardiomyopathy, and heart failure in mice. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 16, 2017 Category: Consumer Health News Tags: Heart Disease Source Type: news

Cardiac Symptoms Before Sudden Cardiac Death Caused by HCM Cardiac Symptoms Before Sudden Cardiac Death Caused by HCM
Hypertrophic cardiomyopathy is a frequent cause of sudden cardiac death in young persons. Do most have prior cardiac symptoms? What type of symptoms do they experience?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

BioVentrix announces the 1st Revivent TC(TM) TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
SAN RAMON, Calif., and XIAMEN, China, March 13, 2017 -- (Healthcare Sales & Marketing Network) -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced commercialization and the first ... Devices, Cardiology BioVentrix, Revivent TC, TransCatheter, Ventricular Enhancement, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2017 Category: Pharmaceuticals Source Type: news

Gene found to cause sudden death in young people
A new gene that can lead to sudden death among young people and athletes has now been identified by an international team of researchers. The gene, called CDH2, causes arrhythmogenic right ventricle cardiomyopathy (ARVC), which is a genetic disorder that predisposes patients to cardiac arrest and is a major cause of unexpected death in seemingly healthy young people. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 10, 2017 Category: Science Source Type: news

Gene found to cause sudden death in young people
(McMaster University) Researchers from Canada, South Africa and Italy have identified a new gene that can lead to sudden death among young people and athletes.The gene, called CDH2, causes arrhythmogenic right ventricle cardiomyopathy (ARVC), which is a genetic disorder that predisposes patients to cardiac arrest and is a major cause of unexpected death in seemingly healthy young people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 9, 2017 Category: Global & Universal Source Type: news

Peripartum cardiomyopathy occurs globally and is not a disease of the poor
(European Society of Cardiology) Peripartum cardiomyopathy occurs globally and is not a disease of the poor, according to research published today in the European Journal of Heart Failure. Cases were reported from many countries for the first time. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 8, 2017 Category: Global & Universal Source Type: news

What is myocarditis? Pop legend George Michael suffered from condition, coroner reveals
MYOCARDITIS is an inflammation of the myocardium, which is a heart muscle. A coroner has revealed pop legend George Michael died from the condition - dilated cardiomyopathy with myocarditis and fatty liver. (Source: Daily Express - Health)
Source: Daily Express - Health - March 7, 2017 Category: Consumer Health News Source Type: news

James, 6, was saved by his mother's kidney
In 2013, James Lewis was diagnosed with incurable restrictive cardiomyopathy (RCM), and after a 11-month battle he also suffered kidney failure. His mother Kate donated her own kidney to save his life. (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2017 Category: Consumer Health News Source Type: news